In previous publications, we have extensively reviewed our approach aimed at rendering tumor cells constitutively positive for MHC class II expression by the genetic transfer of the MHC class II transactivator [24,25,28,29,30] discovered in our laboratory [31,32,33,34], also designated CIITA [35]. Here, CIITA is linked to neoplasm.